N/A
Average AnalystN/A
Top AnalystBearish
Stock Target AdvisorN/A
Average UserUSD 0.11
+0.00 (+0.36)%
USD 0.04B
0.01M
USD -1.00
Based on the Provectus Biopharmaceuticals Inc stock forecast from 0 analysts, the average analyst target price for Provectus Biopharmaceuticals Inc is not available over the next 12 months. Provectus Biopharmaceuticals Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Provectus Biopharmaceuticals Inc is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Provectus Biopharmaceuticals Inc’s stock price was USD 0.1124. Provectus Biopharmaceuticals Inc’s stock price has changed by +24.89% over the past week, +20.34% over the past month and +3.21% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The stock is trading high compared to its peers median on a price to book value basis.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.